Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

Regeneron is hoping a new program will widen patient access to its eye drug without also benefiting the company's rivals — a ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...